Search Results
Mar 05, 2026, 09:23 ET Chelsea Piers Fitness Announces Hudson Square Club, Continuing Its 30-Year Legacy in New York City
FitnessChelsea Piers Fitness is a premium fitness and wellness brand rooted in more than 30 years of excellence and New York City's DNA. Founded as part of the landmark Chelsea Piers Sports & Entertainment Complex on Manhattan's Hudson River in 1995, the brand has grown from its flagship
More news about: Chelsea Piers Fitness
Mar 05, 2026, 09:15 ET Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering
IlluminaIllumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in
More news about: Illumina, Inc.
Mar 05, 2026, 09:11 ET INTRODUCING BREMONT X FELIX THE CAT
Celebrating its passion for 'joyful watchmaking'—an approach long embedded within the brands DNA, and its long-standing commitment to military aviation, Bremont introduces a
More news about: Bremont Watch Company
Mar 05, 2026, 09:04 ET INTRODUCING BREMONT X FELIX THE CAT
Celebrating its passion for 'joyful watchmaking'—an approach long embedded within the brands DNA, and its long-standing commitment to military aviation, Bremont introduces a
More news about: Bremont Watch Company
Mar 05, 2026, 08:29 ET 일루미나, TruPath Genome 출시 및 NovaSeq X 로드맵 공개… Connected Multiomics로 암 연구 혁신 가속
AGBT에서 일루미나 멀티오믹스 솔루션을 활용한 신규 연구 성과 발표2026년 3월 5일 샌디에이고/PRNewswire/ -- DNA 시퀀싱 및 어레이 기반 기술의 글로벌 리더인 일루미나(Illumina Inc., NASDAQ: ILMN)가 유전체 발견의 새로운 시대를 가속화할 강력한 기술 혁신 포트폴리오를 발표했다. 이번에 미국 플로리다주 올랜도에서 열린 2026 유전체 생물학 및 기술 발전 학회(Advances
More news about: Illumina
Mar 05, 2026, 07:24 ET Starti Launches AI Studio - Transforming Creative into Performance
brand materials through a simple URL input, such as a website or product page. The system analyzes the link to capture the brand's visual identity, core DNA, and existing creative assets. Users can also upload additional creatives, images, logos, or brand guidelines to further refine and customize the output.The
More news about: Starti.ai
Mar 05, 2026, 07:14 ET Von Dutch Returns to the Market Under New Ownership, Reemerging as a Nine-Figure Fashion Powerhouse
repositioning, operational excellence, and innovative market expansion. WSG's acquisition model is about identifying labels with cultural heat, creative DNA, and untapped global potential. They scale them with the right resources, partnerships, and strategy while preserving the edge that made them iconic
More news about: Von Dutch
Mar 04, 2026, 17:46 ET H. pylori Infections Market in the 6MM to Observe Stupendous Growth at a CAGR of 9.5% During the Forecast Period (2026-2036) | DelveInsight
strains. Its differentiation lies in a single-molecule dual mechanism combining rifamycin-mediated RNA polymerase inhibition with nitroimidazole-induced DNA damage, providing intrinsic synergy, greater potency, and lower resistance risk without added regimen complexity.Cinclus Pharma's Linaprazan
More news about: DelveInsight Business Research, LLP
Mar 04, 2026, 12:58 ET Yarbo's M Series Hits $1 Million on Kickstarter within 2 Hours
debuting the M Series at CES 2026, Yarbo launched the product through a Kickstarter crowdfunding from March 4 to April 20. Built on Yarbo's modular DNA, the M Series delivers an intelligent, automated approach to everyday yard care while helping reduce time and operational complexity. Key highlights
More news about: Yarbo
Mar 04, 2026, 11:00 ET 'THE STORY OF EVERYTHING' PRESENTS GROUNDBREAKING EVIDENCE THAT HAS REIGNITED THE DEBATE OVER SCIENCE, ORIGINS, AND THE EXISTENCE OF GOD IN THEATRES NATIONWIDE FROM FATHOM ENTERTAINMENT APRIL 30-MAY 6
from nothing and that life arose by accident. Drawing on cutting-edge research into the fine-tuning of physical laws and the information encoded in DNA, The Story of Everything makes a bold case that the most significant scientific discoveries of our era do not point away from God—they
More news about: Fathom Entertainment
Mar 04, 2026, 09:57 ET Coframe Acquires HaystacksAI and Appoints CEO Bo Mohazzabi as VP of GTM to Accelerate its AI Growth Agent
teams superpowers. Customers are already seeing a 10x increase in experiment volume and conversions at a fraction of the cost."The technical DNA is a natural fit. At Haystacks, Mohazzabi built a leading AI product for intent intelligence. By applying LLM-driven behavioral analysis, their
More news about: Coframe Inc.
Mar 04, 2026, 08:52 ET Akeso and INOVIO Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
www.inovio.com.About INOVIO's DNA Medicines PlatformINOVIO's DNA medicines platform has two innovative components: precisely designed DNA plasmids, delivered by INOVIO's proprietary investigational medical device, CELLECTRA. INOVIO uses proprietary technology to design its DNA plasmids, which are
More news about: Akeso, Inc.
Mar 04, 2026, 08:34 ET New Release: The Index of America Unpacks the "DNA of Growth": Why the S&P 500 Remains the Ultimate Vehicle for Generational Wealth
progress."In the book, Bernard unpacks how 500 of the largest publicly traded companies in the U.S. became the bedrock of global equities. By tracing the "DNA of growth" from 20th-century industrial titans to today's digital leaders, the book emphasizes financial literacy and disciplined strategy over risky
More news about: Tom Bernard
Mar 04, 2026, 08:32 ET iLoF and Industry Leader Bluepharma Announce Strategic Collaboration to Deploy AI-Powered Optomics® for Faster Drug Development and to Advance the Future of Personalised Medicine
chain.According to António Lucas Nunes, Director of Science Innovation and Strategic Partnerships at Bluepharma: "Innovation is in Bluepharma's DNA. By partnering with iLoF, we are exploring how cutting-edge photonics and AI can enhance our capability to develop complex formulations with greater
More news about: iLoF
Mar 04, 2026, 08:30 ET Combination Strategies To Improve Radioligand Therapy Efficacy, Upcoming Webinar Hosted by Xtalks
integrating radioligand therapy with complementary modalities such as targeted therapies, chemotherapy, DNA damage repair inhibitors, external beam radiation and immunotherapy, researchers can amplify DNA damage, sensitize tumors, enhance target expression and stimulate anti-tumor immune responses. However,
More news about: Xtalks
Mar 04, 2026, 08:30 ET Study Finds Rice Bran Compound Delivered Through Nanotechnology May Protect Aging Cells
Inside the body, cells are continuously exposed to reactive oxygen species, commonly known as free radicals, which can damage proteins, lipids and DNA. Over time, this oxidative stress accelerates aging and contributes to conditions such as cardiovascular disease, metabolic disorders and other chronic
More news about: University of Arkansas at Pine Bluff
Mar 04, 2026, 08:05 ET INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
tumors.About INOVIO's DNA Medicines PlatformINOVIO's DNA medicines platform has two innovative components: precisely designed DNA plasmids, delivered by INOVIO's proprietary investigational medical device, CELLECTRA. INOVIO uses proprietary technology to design its DNA plasmids, which are
More news about: INOVIO Pharmaceuticals, Inc.
Mar 04, 2026, 08:00 ET Minaris Launches AgentSCREEN Adventitious Virus Detection by NGS to Simplify Viral Safety Testing for Cell Banks and Cell-Based Samples
messenger RNA (mRNA) in a cell bank sample for the presence of viral RNA transcripts and is designed to detect active viral infections from RNA and DNA viruses. A custom GAMP 5 validated bioinformatics pipeline compares sequencing data to the Reference Viral Database (RVDB) curated by CBER/FDA to accurately
More news about: Minaris Advanced Therapies
Mar 04, 2026, 05:46 ET Posilnenie domovov, dodanie energie do životov: Vaša energia, naša budúcnosť
81. výročia UNESCO a ako oficiálny partner Svetového dňa inžinierstva pre udržateľný rozvoj 2026 prináša spoločnosť Zendure revolúciu v
More news about: Zendure DE GmbH
Mar 04, 2026, 05:45 ET MDA SPACE REPORTS FOURTH QUARTER AND FISCAL 2025 RESULTS
vision into an achievable mission – bringing to bear a one-of-a-kind mix of experience, engineering excellence and wide-eyed wonder that's been in our DNA since day one. For those who dream big and push boundaries on the ground and in the stars to change the world for the better, we'll take you there. For
More news about: MDA Space
Mar 03, 2026, 22:11 ET DNA Prep Academy and Sports Academy Announce Transformational Partnership to Launch DNA Sports Academy
said Paul Holyfield, CEO at DNA Prep Academy. "By aligning elite human performance with accredited education and intentional mentorship, DNA Sports Academy creates a clear, disciplined pathway for long-term success."A Mission Bigger Than SportThe launch of DNA Sports Academy reflects a broader
More news about: Sports Academy
Mar 03, 2026, 21:00 ET Gene Solutions Announces Strategic Entry into Türkiye with Robust Real-World Evidence at the 2nd International Hereditary Cancers Congress 2026
scalability for population-level impact in high-risk cohorts.Dr. Duy Sinh Nguyen, Oncology Medical Director at Gene Solutions, presented "Beyond DNA: Integrated Comprehensive Genomic & Transcriptomic Profiling with Longitudinal MRD Monitoring". He introduced the K-4CARE platform, a unified
More news about: Gene Solutions Genomics Pte Ltd
Mar 03, 2026, 16:00 ET Harley-Davidson, Inc. to Present at Citi's 2026 Global Consumer & Retail Conference
all-electric motorcycle company in the United States. LiveWire is the future in the making for the pursuit of urban adventure and beyond. Drawing on its DNA as an agile disruptor from the lineage of Harley-Davidson and capitalizing on a decade of learnings in the EV sector, LiveWire's ambition is to be the
More news about: Harley-Davidson, Inc.
Mar 03, 2026, 14:36 ET Hematologic Malignancies Market to Reach USD 128.48 Billion by 2032, Driven by Immunotherapy, CAR-T, and Precision Oncology - Credence Research Inc.
Rapid AML Panel, HRD testing within OmniSeq INSIGHT, and enhanced FDA-approved companion diagnostics for solid tumors.October 2025 – Integrated DNA Technologies (IDT) & Hamilton: Entered a strategic partnership to automate customizable NGS workflows for comprehensive genomic profiling on Hamilton
More news about: Credence Research Inc.
Mar 03, 2026, 11:13 ET Droplet Biosciences Accelerates Residual Cancer Detection with NVIDIA
highlights the use of NVIDIA Parabricks, a GPU-accelerated software suite designed to drastically speed up genomic data analysis for DNA sequencing. Using Parabricks, Droplet has achieved an order-of-magnitude reduction in the analysis time required across critical bioinformatics steps.
More news about: Droplet Biosciences, Inc